PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
MEDP vs. INMD
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between MEDP and INMD is 0.41, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.00.4

Performance

MEDP vs. INMD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Medpace Holdings, Inc. (MEDP) and InMode Ltd. (INMD). The values are adjusted to include any dividend payments, if applicable.

-30.00%-20.00%-10.00%0.00%10.00%AugustSeptemberOctoberNovemberDecember2025
-19.93%
-5.09%
MEDP
INMD

Key characteristics

Sharpe Ratio

MEDP:

0.44

INMD:

-0.53

Sortino Ratio

MEDP:

0.84

INMD:

-0.52

Omega Ratio

MEDP:

1.13

INMD:

0.93

Calmar Ratio

MEDP:

0.57

INMD:

-0.27

Martin Ratio

MEDP:

1.09

INMD:

-0.75

Ulcer Index

MEDP:

16.94%

INMD:

31.00%

Daily Std Dev

MEDP:

42.02%

INMD:

43.56%

Max Drawdown

MEDP:

-42.87%

INMD:

-84.79%

Current Drawdown

MEDP:

-26.23%

INMD:

-82.84%

Fundamentals

Market Cap

MEDP:

$10.49B

INMD:

$1.28B

EPS

MEDP:

$11.44

INMD:

$1.83

PE Ratio

MEDP:

29.49

INMD:

9.17

PEG Ratio

MEDP:

1.60

INMD:

2.90

Total Revenue (TTM)

MEDP:

$1.57B

INMD:

$303.13M

Gross Profit (TTM)

MEDP:

$470.75M

INMD:

$244.84M

EBITDA (TTM)

MEDP:

$349.74M

INMD:

$66.89M

Returns By Period

In the year-to-date period, MEDP achieves a 1.54% return, which is significantly higher than INMD's 0.54% return.


MEDP

YTD

1.54%

1M

1.92%

6M

-19.93%

1Y

15.72%

5Y*

30.06%

10Y*

N/A

INMD

YTD

0.54%

1M

-2.33%

6M

-5.09%

1Y

-25.68%

5Y*

-5.72%

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

MEDP vs. INMD — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MEDP
The Risk-Adjusted Performance Rank of MEDP is 6161
Overall Rank
The Sharpe Ratio Rank of MEDP is 6262
Sharpe Ratio Rank
The Sortino Ratio Rank of MEDP is 5555
Sortino Ratio Rank
The Omega Ratio Rank of MEDP is 5858
Omega Ratio Rank
The Calmar Ratio Rank of MEDP is 6969
Calmar Ratio Rank
The Martin Ratio Rank of MEDP is 5959
Martin Ratio Rank

INMD
The Risk-Adjusted Performance Rank of INMD is 2323
Overall Rank
The Sharpe Ratio Rank of INMD is 1818
Sharpe Ratio Rank
The Sortino Ratio Rank of INMD is 1919
Sortino Ratio Rank
The Omega Ratio Rank of INMD is 1919
Omega Ratio Rank
The Calmar Ratio Rank of INMD is 2929
Calmar Ratio Rank
The Martin Ratio Rank of INMD is 3030
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

MEDP vs. INMD - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Medpace Holdings, Inc. (MEDP) and InMode Ltd. (INMD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for MEDP, currently valued at 0.44, compared to the broader market-2.000.002.004.000.44-0.53
The chart of Sortino ratio for MEDP, currently valued at 0.84, compared to the broader market-4.00-2.000.002.004.000.84-0.52
The chart of Omega ratio for MEDP, currently valued at 1.13, compared to the broader market0.501.001.502.001.130.93
The chart of Calmar ratio for MEDP, currently valued at 0.57, compared to the broader market0.002.004.006.000.57-0.27
The chart of Martin ratio for MEDP, currently valued at 1.09, compared to the broader market-10.000.0010.0020.0030.001.09-0.75
MEDP
INMD

The current MEDP Sharpe Ratio is 0.44, which is higher than the INMD Sharpe Ratio of -0.53. The chart below compares the historical Sharpe Ratios of MEDP and INMD, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.00AugustSeptemberOctoberNovemberDecember2025
0.44
-0.53
MEDP
INMD

Dividends

MEDP vs. INMD - Dividend Comparison

Neither MEDP nor INMD has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

MEDP vs. INMD - Drawdown Comparison

The maximum MEDP drawdown since its inception was -42.87%, smaller than the maximum INMD drawdown of -84.79%. Use the drawdown chart below to compare losses from any high point for MEDP and INMD. For additional features, visit the drawdowns tool.


-80.00%-60.00%-40.00%-20.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-26.23%
-82.84%
MEDP
INMD

Volatility

MEDP vs. INMD - Volatility Comparison

The current volatility for Medpace Holdings, Inc. (MEDP) is 9.52%, while InMode Ltd. (INMD) has a volatility of 10.80%. This indicates that MEDP experiences smaller price fluctuations and is considered to be less risky than INMD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%AugustSeptemberOctoberNovemberDecember2025
9.52%
10.80%
MEDP
INMD

Financials

MEDP vs. INMD - Financials Comparison

This section allows you to compare key financial metrics between Medpace Holdings, Inc. and InMode Ltd.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab